Strumento inattivo

Altre lingue Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE

Azioni

IL0006290147

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024	03/07
En Direct des Marchés : Renault, Carrefour, Airbus, Sodexo, Ipsen, Elis, Mersen, Blackstone, Tesla...	02/07
Juillet attaque (timidement) dans le vert	02/07
Bolsa de Madrid: Julio comienza (tímidamente) en verde	02/07
Sector Update: Health Care Stocks Retreat Late Afternoon	01/07
Sector Update: Health Care Stocks Slipping in Afternoon Trading	01/07
Teva Pharmaceuticals Faces FTC Probe on Patent Listings	01/07
Correction: Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity	01/07
Teva Pharmaceutical Faces FTC Investigation for Patents, Washington Post Says	01/07
Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity	01/07
Teva Pharmaceuticals Faces FTC Probe on Patent Listings	01/07
Teva Pharmaceuticals Faces FTC Probe on Patent Listings	01/07
FTC Opens Investigation Into Teva Pharmaceuticals	01/07
FTC Opens Investigation Into Teva Pharmaceuticals, Washington Post Reports	01/07
Vanda Pharmaceuticals Says Federal Court Allows Patent Lawsuit Over Hetlioz	01/07
Les nouvelles données portant sur AJOVY® (fremanezumab) dans la prévention de la migraine remettent en question les pauses thérapeutiques	29/06
Neue Daten zu AJOVY® (Fremanezumab) zur Migräneprävention stellen Behandlungspausen in Frage	28/06
New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses	28/06
Teva Pharmaceutical Industries Ltd Announces New AJOVY® (Fremanezumab) Migraine Prevention Data Challenges Treatment Pauses	28/06
Global markets live: UBS, Boeing, AT&T, Rivian, Nvidia, Tesla...	25/06

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

In prima pagina

Teva Pharmaceutical Industries Limited: costretta a ulteriori cessioni

01 febbraio 2024 alle 17:43

Il CEO di Teva sul secondo trimestre e sul potenziale accordo con il Dipartimento di Giustizia degli Stati Uniti

02 agosto 2023 alle 21:19